TransEnterix is currently developing a patient-side robotic system called the SurgiBot™ System. The system is designed to be controlled directly by the surgeon, with enhanced vision and robotic motion. SurgiBot System design incorporates deployment of flexible instruments and a high-definition 3D articulating scope through a single incision.
The SurgiBot System is currently in development and has not yet been cleared by the FDA for sale in the United States or by other regulatory authorities for sale outside the United States.
April 22, 2015
TransEnterix Schedules First Quarter 2015 Financial and Operating Results Conference Call for May 6, 2015
April 16, 2015
TransEnterix Announces Completion of GLP Studies
April 01, 2015
MedDevice Online: Developing A Surgical Robotics System That Doctors Really Want — And Hospitals Can Afford
May 05, 2015
BioTuesdays: TransEnterix readying FDA filing of SurgiBot in midyear